DK0525034T3 - Antigen/anti-antigenspaltning - Google Patents

Antigen/anti-antigenspaltning

Info

Publication number
DK0525034T3
DK0525034T3 DK91907924.4T DK91907924T DK0525034T3 DK 0525034 T3 DK0525034 T3 DK 0525034T3 DK 91907924 T DK91907924 T DK 91907924T DK 0525034 T3 DK0525034 T3 DK 0525034T3
Authority
DK
Denmark
Prior art keywords
antigen
pct
hapten
sec
antigenspaltning
Prior art date
Application number
DK91907924.4T
Other languages
English (en)
Inventor
Steinar Funderud
John Afseth
Laurent Caignault
Mohamad Mortada
Original Assignee
Dynal As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynal As filed Critical Dynal As
Application granted granted Critical
Publication of DK0525034T3 publication Critical patent/DK0525034T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
DK91907924.4T 1990-04-09 1991-04-09 Antigen/anti-antigenspaltning DK0525034T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007966A GB9007966D0 (en) 1990-04-09 1990-04-09 Antigen/anti-antigen cleavage

Publications (1)

Publication Number Publication Date
DK0525034T3 true DK0525034T3 (da) 1996-01-08

Family

ID=10674119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91907924.4T DK0525034T3 (da) 1990-04-09 1991-04-09 Antigen/anti-antigenspaltning

Country Status (10)

Country Link
US (1) US5429927A (da)
EP (1) EP0525034B1 (da)
JP (1) JP3012326B2 (da)
AT (1) ATE131285T1 (da)
AU (1) AU654278B2 (da)
CA (1) CA2080118C (da)
DE (1) DE69115267T2 (da)
DK (1) DK0525034T3 (da)
GB (1) GB9007966D0 (da)
WO (1) WO1991015766A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
TW371714B (en) * 1993-12-01 1999-10-11 Fiberchem Inc Ultrasensitive competitive immunoassays using optical waveguides
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO961031D0 (no) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
US6348318B1 (en) 1997-04-04 2002-02-19 Biosite Diagnostics Methods for concentrating ligands using magnetic particles
US6193892B1 (en) 1999-03-03 2001-02-27 Promega Corporation Magnetic separation assembly and method
US6503273B1 (en) * 1999-11-22 2003-01-07 Cyograft Tissue Engineering, Inc. Tissue engineered blood vessels and methods and apparatus for their manufacture
AU2002240818C1 (en) 2001-03-14 2008-11-06 Agilent Technologies, Inc. MHC molecule constructs and their uses for diagnosis and therapy
EP1451299A4 (en) * 2001-12-11 2008-03-05 Cytograft Tissue Engineering I CELL AGENTS MADE BY TISSUE ENGINEERING, METHOD FOR THE PRODUCTION AND USE THEREOF
FR2845097B1 (fr) * 2002-10-01 2006-06-16 Metis Biotechnologies Procede de detection et de comptage de microorganismes dans un echantillon
WO2008140573A2 (en) * 2006-11-15 2008-11-20 Invitrogen Dynal As Methods for reversibly binding a biotin compound to a support
US20100189712A1 (en) * 2006-11-17 2010-07-29 Cytograft Tissue Engineering, Inc. Preparation And Use Of Cell-Synthesized Threads
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
EP3620465A1 (en) 2007-07-03 2020-03-11 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010005753A1 (en) * 2008-06-16 2010-01-14 Cytograft Tissue Engineering, Inc. Arterial implants
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US8790916B2 (en) * 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
US8747084B2 (en) 2010-07-21 2014-06-10 Aperia Technologies, Inc. Peristaltic pump
ES2619629T3 (es) 2012-03-20 2017-06-26 Aperia Technologies Sistema de inflado de neumáticos
US20150204857A1 (en) * 2012-08-23 2015-07-23 Stemcell Technologies Inc. Compositions and Methods for Rapid and Reversible Biomolecular Labeling
US10196631B2 (en) * 2012-10-23 2019-02-05 Miltenyi Biotec Gmbh Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
US10245908B2 (en) 2016-09-06 2019-04-02 Aperia Technologies, Inc. System for tire inflation
US10144254B2 (en) 2013-03-12 2018-12-04 Aperia Technologies, Inc. Tire inflation system
US11453258B2 (en) 2013-03-12 2022-09-27 Aperia Technologies, Inc. System for tire inflation
US9604157B2 (en) 2013-03-12 2017-03-28 Aperia Technologies, Inc. Pump with water management
WO2020112686A1 (en) 2018-11-27 2020-06-04 Aperia Technologies, Inc. Hub-integrated inflation system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861705A (en) * 1983-01-31 1989-08-29 Yeda Research And Development Company, Ltd. Method for removing components of biological fluids
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
EP0170302A1 (fr) * 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
WO1988002776A1 (en) * 1986-10-10 1988-04-21 Peter Grandics A novel immunoaffinity purification system
JPH04505547A (ja) * 1988-01-04 1992-10-01 イー・アイ・デユポン・ド・ネモアース・アンド・コンパニー 細胞混合物から特定の細胞を単離するための多段アフィニティー法
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
GB8929297D0 (en) * 1989-12-29 1990-02-28 Dynal As Method of separation

Also Published As

Publication number Publication date
US5429927A (en) 1995-07-04
AU654278B2 (en) 1994-11-03
ATE131285T1 (de) 1995-12-15
WO1991015766A1 (en) 1991-10-17
EP0525034B1 (en) 1995-12-06
DE69115267T2 (de) 1996-07-18
JPH05506927A (ja) 1993-10-07
EP0525034A1 (en) 1993-02-03
CA2080118A1 (en) 1991-10-10
JP3012326B2 (ja) 2000-02-21
CA2080118C (en) 2005-07-26
GB9007966D0 (en) 1990-06-06
AU7688791A (en) 1991-10-30
DE69115267D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
DK0525034T3 (da) Antigen/anti-antigenspaltning
GB9024771D0 (en) Assay
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
DK0660930T3 (da) Forbedret fremgangsmåde til påvisning af specifikke målceller i specialiseret eller blandet cellepopulation samt opløsninge
DK83580A (da) Fremgangsmaade til magnetisk separering af celler og lignende og mikrokugler til anvendelse deri
NO953548D0 (no) Immobilisering og separering av celler og andre partikler
DE69021953D1 (de) Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
ATE179799T1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
NO882299D0 (no) Fremgangsmaate for magnetisk separering av merket reagens i en immunometrisk bindings-analyse.
CA2045475A1 (en) Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
DE69430846T2 (de) Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
GB2214295B (en) "hapten determination method, use and components"
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
DK0769144T3 (da) Assay for inhibitorer for DP-1 og andre DP-proteiner
PT650523E (pt) Antigene cdw52 recombinante
ES2029890T3 (es) Inmunoensayo.
DK673789D0 (da) Monoklonalt antistof, som specifikt binder til kc-48-antigenet i neutrophiler og eosinophiler, samt hybridomocellelinie, som producerer antistoffet
UA12580A (uk) Спосіб оціhки ефективhості гемосорбції у хворих hа броhхіальhу астму